TORONTO, June 6 /CNW/ - Patheon (TSX:PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, today announced its results for the second quarter ended April 30, 2008. (All amounts are in U.S. dollars unless otherwise indicated).
